Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
The Henry Jackson M. Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Physiol Rep. 2022 Feb;10(3):e15181. doi: 10.14814/phy2.15181.
The mechanisms by which lower limb ischemia/reperfusion induces acute kidney injury (AKI) remain largely uncharacterized. We hypothesized that tourniquet-induced lower limb ischemia/reperfusion (TILLIR) would inhibit mitochondrial function in the renal cortex. We used a murine model to show that TILLIR of the high thigh regions inflicted time-dependent AKI as determined by renal function and histology. This effect was associated with decreased activities of mitochondrial complexes I, II, V and citrate synthase in the kidney cortex. Moreover, TILLIR reduced mRNA levels of a master regulator of mitochondrial biogenesis PGC-1α, and its downstream genes NDUFS1 and ATP5o in the renal cortex. TILLIR also increased serum corticosterone concentrations. TILLIR did not significantly affect protein levels of the critical regulators of mitophagy PINK1 and PARK2, mitochondrial transport proteins Tom20 and Tom70, or heat-shock protein 27. TILLIR had no significant effect on mitochondrial oxidative stress as determined by mitochondrial ability to generate reactive oxygen species, protein carbonylation, or protein levels of MnSOD and peroxiredoxin1. However, TILLIR inhibited classic autophagic flux by increasing p62 protein abundance and preventing the conversion of LC3-I to LC3-II. TILLIR increased phosphorylation of cytosolic and mitochondrial ERK1/2 and mitochondrial AKT1, as well as mitochondrial SGK1 activity. In conclusion, lower limb ischemia/reperfusion induces distal AKI by inhibiting mitochondrial function through reducing mitochondrial biogenesis. This AKI occurs without significantly affecting PINK1-PARK2-mediated mitophagy or mitochondrial oxidative stress in the kidney cortex.
肢体缺血/再灌注引起急性肾损伤(AKI)的机制在很大程度上仍未被阐明。我们假设止血带诱导的下肢缺血/再灌注(TILLIR)会抑制肾脏皮质中的线粒体功能。我们使用一种小鼠模型表明,高大腿区域的 TILLIR 会导致肾功能和组织学确定的时间依赖性 AKI。这种效应与肾脏皮质中线粒体复合物 I、II、V 和柠檬酸合酶活性的降低有关。此外,TILLIR 降低了肾脏皮质中线粒体生物发生的主要调节因子 PGC-1α 及其下游基因 NDUFS1 和 ATP5o 的 mRNA 水平。TILLIR 还增加了血清皮质酮浓度。TILLIR 对关键的线粒体自噬调节因子 PINK1 和 PARK2、线粒体转运蛋白 Tom20 和 Tom70 或热休克蛋白 27 的蛋白水平没有显著影响。TILLIR 对线粒体氧化应激没有显著影响,如线粒体产生活性氧、蛋白质羰基化或 MnSOD 和过氧化物酶 1 的蛋白水平所确定的那样。然而,TILLIR 通过增加 p62 蛋白丰度并阻止 LC3-I 转化为 LC3-II 来抑制经典的自噬通量。TILLIR 增加了细胞质和线粒体 ERK1/2 以及线粒体 AKT1 的磷酸化,以及线粒体 SGK1 的活性。总之,肢体缺血/再灌注通过减少线粒体生物发生来抑制线粒体功能,从而导致远端 AKI。这种 AKI 的发生不会显著影响肾脏皮质中 PINK1-PARK2 介导的线粒体自噬或线粒体氧化应激。